564
Views
20
CrossRef citations to date
0
Altmetric
Articles

Selected plant essential oils and their main active components, a promising approach to inhibit aflatoxigenic fungi and aflatoxin production in food

, , , , &
Pages 1581-1595 | Received 03 Oct 2017, Accepted 11 Dec 2017, Published online: 17 Jan 2018
 

ABSTRACT

Recent research has showed that Aspergillus flavus and Aspergillus parasiticus are aflatoxigenic species that can become very competitive in the framework of climate change. Aflatoxins show carcinogenic, mutagenic, immunotoxic and teratogenic effects on human and animals. Effective and sustainable measures to inhibit these species and aflatoxins in food are required. Origanum vulgare and Cinnamomum zeylanicum essential oils (EOs) and their major active constituents, carvacrol and cinnamaldehyde, respectively, were assayed for inhibiting these species and aflatoxin production in maize extract medium under different environmental conditions. Doses of 10–1000 mg l−1 were assayed and the effective doses for 50 (ED50) and 90% (ED90) growth inhibition were determined. The ED50 of cinnamaldehyde, carvacrol, oregano EO, and cinnamon EO against A. flavus were in the ranges 49–52.6, 98–145, 152–505, 295–560 mg l−1 and against A. parasiticus in the ranges 46–55.5, 101–175, 260–425 and 490–675 mg l−1, respectively, depending on environmental conditions. In A. flavus treatments ED90 were in the ranges 89.7–90.5, 770–860 and 820–>1000 mg l−1 for cinnamaldehyde, carvacrol and cinnamon EO, and in A. parasiticus treatments in the ranges 89–91, 855–>1000 and 900–>1000 mg l−1, respectively. ED90 values for oregano EO against both species were >1000 mg l−1. Growth rates of both species were higher at 37 than at 25°C and at 0.99 than at 0.96 aw. Aflatoxin production was higher at 25 than at 37°C. Stimulation of aflatoxin production was observed at low doses except for cinnamaldehyde treatments. The effectiveness of EOs and their main constituents to inhibit fungal growth and aflatoxin production in contact assays was lower than in vapour phase assays using bioactive EVOH-EO films previously reported.

Acknowledgments

Eva M. Mateo is grateful to Ministerio de Economía y Competitividad (MINECO, Spanish government) for a ‘Juan de la Cierva’ postdoctoral contract (Ref. FJCI-2015-25992). José V. Gómez is grateful to MINECO for a Ph.D. contract (BES-2015-071242).

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This study was financed by: the European Regional Development Fund (ERDF) [project number AGL2014-53928-C2-1-R].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.